AXL receptor tyrosine kinase is required for t cell priming and antiviral immunity

eLife

Volumn 5, Issue JUNE2016, 2016, Pages

  Schmid, Edward T ^a   Pang, Iris K ^a,d   Carrera Silva, Eugenio A ^a,e   Bosurgi, Lidia ^a   Miner, Jonathan J ^b   Diamond, Michael S ^b   Iwasaki, Akiko ^a,c   Rothlin, Carla V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 1BETA; PROTEIN TYROSINE KINASE; AXL RECEPTOR TYROSINE KINASE; ONCOPROTEIN;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; ARTICLE; AXL GENE; BONE MARROW CELL; BONE MARROW DERIVED DENDRITIC CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLUENZA A VIRUS; LYMPH NODE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL CLEARANCE; VIRUS LOAD; WEST NILE VIRUS; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; ORTHOMYXOVIRUS INFECTION; T LYMPHOCYTE; WEST NILE FEVER;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; INFLUENZA A VIRUS; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; T-LYMPHOCYTES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84978880909     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.12414.001     Document Type: Article

References (45)

1. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30:556-565. doi: 10.1016/j.immuni.2009.02.005
2. Ballesteros-Tato A, León B, Lund FE, Randall TD. 2010. Temporal changes in dendritic cell subsets, crosspriming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nature Immunology 11:216-224. doi: 10.1038/ni.1838
3. Bender BS, Croghan T, Zhang L, Small PA. 1992. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. Journal of Experimental Medicine 175:1143-1145. doi: 10.1084/jem.175.4.1143
4. Bhattacharyya S, Zagórska A, Lew ED, Shrestha B, Rothlin CV, Naughton J, Diamond MS, Lemke G, Young JA. 2013. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host and Microbe 14:136-147. doi: 10.1016/j.chom.2013.07.005
5. Caton ML, Smith-Raska MR, Reizis B. 2007. Notch-RBP-J signaling controls the homeostasis of CD8-dendritic cells in the spleen. Journal of Experimental Medicine 204:1653-1664. doi: 10.1084/jem.20062648
6. Deng L, Zhou JF, Sellers RS, Li JF, Nguyen AV, Wang Y, Orlofsky A, Liu Q, Hume DA, Pollard JW, Augenlicht L, Lin EY. 2010. A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. The American Journal of Pathology 176:952-967. doi: 10.2353/ajpath.2010.090622
7. Drayman N, Glick Y, Ben-nun-shaul O, Zer H, Zlotnick A, Gerber D, Schueler-Furman O, Oppenheim A. 2013. Pathogens use structural mimicry of native host ligands as a mechanism for host receptor engagement. Cell Host and Microbe 14:63-73. doi: 10.1016/j.chom.2013.05.005
8. Fujimori T, Grabiec AM, Kaur M, Bell TJ, Fujino N, Cook PC, Svedberg FR, MacDonald AS, Maciewicz RA, Singh D, Hussell T. 2015. The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung. Mucosal Immunology 8:1021-1030. doi: 10.1038/mi.2014.129
9. Gallucci S, Lolkema M, Matzinger P. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nature Medicine 5:1249-1255. doi: 10.1038/15200
10. Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, Hashimoto D, Price J, Yin N, Bromberg J, Lira SA, Stanley ER, Nussenzweig M, Merad M. 2009. The origin and development of nonlymphoid tissue CD103+ DCs. Journal of Experimental Medicine 206:3115-3130. doi: 10.1084/jem.20091756
11. Graham DK, DeRyckere D, Davies KD, Earp HS. 2014. The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. Nature Reviews Cancer 14:769-785. doi: 10.1038/nrc3847
12. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213-223. doi: 10.1016/j.immuni.2011.02.006
13. Helft J, Manicassamy B, Guermonprez P, Hashimoto D, Silvin A, Agudo J, Brown BD, Schmolke M, Miller JC, Leboeuf M, Murphy KM, García-Sastre A, Merad M. 2012. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. Journal of Clinical Investigation 122:4037-4047. doi: 10.1172/JCI60659
14. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. Journal of Experimental Medicine 206:79-87. doi: 10.1084/jem.20081667
15. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proceedings of the Royal Society of London. Series B, Biological Sciences 147:258-267. doi: 10.1098/rspb.1957.0048
16. Iwasaki A, Pillai PS. 2014. Innate immunity to influenza virus infection. Nature Reviews Immunology 14:315-328. doi: 10.1038/nri3665
17. Kanneganti TD. 2010. Central roles of NLRs and inflammasomes in viral infection. Nature Reviews Immunology 10:688-698. doi: 10.1038/nri2851
18. Kim TS, Gorski SA, Hahn S, Murphy KM, Braciale TJ. 2014. Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism. Immunity 40: 400-413. doi: 10.1016/j.immuni.2014.02.004
19. Lew ED, Oh J, Burrola PG, Lax I, Zagórska A, Través PG, Schlessinger J, Lemke G. 2014. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. eLife 3:e03385. doi: 10.7554/eLife.03385
20. Lu Q, Gore M, Zhang Q, Camenisch T, Boast S, Casagranda F, Lai C, Skinner MK, Klein R, Matsushima GK, Earp HS, Goff SP, Lemke G. 1999. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 398:723-728. doi: 10.1038/19554
21. Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, García-Sastre A. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proceedings of the National Academy of Sciences of the United States of America 107:11531-11536. doi: 10.1073/pnas.0914994107
22. Mayer-Barber KD, Andrade BB, Barber DL, Hieny S, Feng CG, Caspar P, Oland S, Gordon S, Sher A. 2011. Innate and adaptive interferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35:1023-1034. doi: 10.1016/j.immuni.2011.12.002
23. Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, Kugler D, Hieny S, Caspar P, Núñez G, Schlueter D, Flavell RA, Sutterwala FS, Sher A. 2010. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. Journal of Immunology 184:3326-3330. doi: 10.4049/jimmunol.0904189
24. McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. 2015. Type I interferons in infectious disease. Nature Reviews Immunology 15:87-103. doi: 10.1038/nri3787
25. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. 2012. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host and Microbe 12:544-557. doi: 10.1016/j.chom.2012.08.009
26. Miner JJ, Daniels BP, Shrestha B, Proenca-Modena JL, Lew ED, Lazear HM, Gorman MJ, Lemke G, Klein RS, Diamond MS. 2015. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nature Medicine 21:1464-1472. doi: 10.1038/nm.3974
27. Montoya M, Schiavoni G, Mattei F, Gresser I, Belardelli F, Borrow P, Tough DF. 2002. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99:3263-3271. doi: 10.1182/blood.V99.9.3263
28. Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM, Chen IS. 2011. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host and Microbe 9:286-298. doi: 10.1016/j.chom.2011.03.012
29. Pang IK, Ichinohe T, Iwasaki A. 2013. IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8+ T cell responses to influenza A virus. Nature Immunology 14:246-253. doi: 10.1038/ni.2514
30. Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, Merkler D, Detje C, Gutcher I, Mages J, Lang R, Martin R, Gold R, Becher B, Bruck W, Kalinke U. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28:675-686. doi: 10.1016/j.immuni.2008.03.011
31. Ramos HJ, Lanteri MC, Blahnik G, Negash A, Suthar MS, Brassil MM, Sodhi K, Treuting PM, Busch MP, Norris PJ, Gale M. 2012. IL-1b signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathogens 8:e1003039. doi: 10.1371/journal.ppat.1003039
32. Rothlin CV, Carrera-Silva EA, Bosurgi L, Ghosh S. 2015. TAM receptor signaling in immune homeostasis. Annual Review of Immunology 33:355-391. doi: 10.1146/annurev-immunol-032414-112103
33. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131:1124-1136. doi: 10.1016/j.cell.2007.10.034
34. Schmitz N, Kurrer M, Bachmann MF, Kopf M. 2005. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. Journal of Virology 79:6441-6448. doi: 10.1128/JVI.79.10.6441-6448.2005
35. Scutera S, Fraone T, Musso T, Cappello P, Rossi S, Pierobon D, Orinska Z, Paus R, Bulfone-Paus S, Giovarelli M. 2009. Survival and migration of human dendritic cells are regulated by an IFN--inducible Axl/Gas6 pathway. Journal of Immunology 183:3004-3013. doi: 10.4049/jimmunol.0804384
36. Shimojima M, Ikeda Y, Kawaoka Y. 2007. The mechanism of Axl-mediated Ebola virus infection. The Journal of Infectious Diseases 196 Suppl 2:S259-263. doi: 10.1086/520594
37. Shimojima M, Stroher U, Ebihara H, Feldmann H, Kawaoka Y. 2012. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. Journal of Virology 86:2067-2078. doi: 10.1128/JVI.06451-11
38. Strutt TM, McKinstry KK, Marshall NB, Vong AM, Dutton RW, Swain SL. 2013. Multipronged CD4(+) T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunological Reviews 255:149-164. doi: 10.1111/imr.12088
39. Sun J, Braciale TJ. 2013. Role of T cell immunity in recovery from influenza virus infection. Current Opinion in Virology 3:425-429. doi: 10.1016/j.coviro.2013.05.001
40. Taniguchi T, Fujii-Kuriyama Y, Muramatsu M. 1980. Molecular cloning of human interferon cDNA. Proceedings of the National Academy of Sciences of the United States of America 77:4003-4006. doi: 10.1073/pnas.77.7.4003
41. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340:207-211. doi: 10.1126/science.1235214
42. Thomas PG, Dash P, Aldridge JR, Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL, Doherty PC, Kanneganti TD. 2009. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30:566-575. doi: 10.1016/j.immuni.2009.02.006
43. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340:202-207. doi: 10.1126/science.1235208
44. Wu H, Haist V, Baumgartner W, Schughart K. 2010. Sustained viral load and late death in Rag2-/-mice after influenza A virus infection. Virology Journal 7:172. doi: 10.1186/1743-422X-7-172
45. Zagórska A, Través PG, Lew ED, Dransfield I, Lemke G. 2014. Diversification of TAM receptor tyrosine kinase function. Nature Immunology 15:920-928. doi: 10.1038/ni.2986